81P Predictive molecular parameters of pneumonitis development in stage IIIa NSCLC patients treated with neo-adjuvant chemo-immunotherapy from NADIM clinical trial

Journal of Thoracic Oncology(2021)

Cited 0|Views2
No score
Key words
pneumonitis development,stage iiia nsclc patients,neo-adjuvant,chemo-immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined